» Articles » PMID: 37596064

Praemonitus Praemunitus: Can We Forecast and Prepare for Future Viral Disease Outbreaks?

Abstract

Understanding the origins of past and present viral epidemics is critical in preparing for future outbreaks. Many viruses, including SARS-CoV-2, have led to significant consequences not only due to their virulence, but also because we were unprepared for their emergence. We need to learn from large amounts of data accumulated from well-studied, past pandemics and employ modern informatics and therapeutic development technologies to forecast future pandemics and help minimize their potential impacts. While acknowledging the complexity and difficulties associated with establishing reliable outbreak predictions, herein we provide a perspective on the regions of the world that are most likely to be impacted by future outbreaks. We specifically focus on viruses with epidemic potential, namely SARS-CoV-2, MERS-CoV, DENV, ZIKV, MAYV, LASV, noroviruses, influenza, Nipah virus, hantaviruses, Oropouche virus, MARV, and Ebola virus, which all require attention from both the public and scientific community to avoid societal catastrophes like COVID-19. Based on our literature review, data analysis, and outbreak simulations, we posit that these future viral epidemics are unavoidable, but that their societal impacts can be minimized by strategic investment into basic virology research, epidemiological studies of neglected viral diseases, and antiviral drug discovery.

Citing Articles

Association between breast cancer risk factors and blood microbiome in patients with breast cancer.

An J, Kwon H, Oh S, Kim Y Sci Rep. 2025; 15(1):6115.

PMID: 39972005 PMC: 11840066. DOI: 10.1038/s41598-025-90180-3.


On the importance of data curation for knowledge mining in antiviral research.

Martin H, Melo-Filho C, Zakharov A, Muratov E, Tropsha A Sci Prog. 2025; 108(1):368504241301535.

PMID: 39840476 PMC: 11752173. DOI: 10.1177/00368504241301535.


Meeting report of the 37th International Conference on Antiviral Research in Gold Coast, Australia, May 20-24, 2024, organized by the International Society for Antiviral Research.

Welch S, Bilello J, Carter K, Delang L, Dirr L, Durantel D Antiviral Res. 2024; 232:106037.

PMID: 39542140 PMC: 11871649. DOI: 10.1016/j.antiviral.2024.106037.


Oropouche virus: A neglected global arboviral threat.

Zhang Y, Liu X, Wu Z, Feng S, Lu K, Zhu W Virus Res. 2024; 341:199318.

PMID: 38224842 PMC: 10827532. DOI: 10.1016/j.virusres.2024.199318.


Small molecule antiviral compound collection (SMACC): A comprehensive, highly curated database to support the discovery of broad-spectrum antiviral drug molecules.

Martin H, Melo-Filho C, Korn D, Eastman R, Rai G, Simeonov A Antiviral Res. 2023; 217:105620.

PMID: 37169224 PMC: 11069349. DOI: 10.1016/j.antiviral.2023.105620.

References
1.
Gubler D, Vasilakis N, Musso D . History and Emergence of Zika Virus. J Infect Dis. 2017; 216(suppl_10):S860-S867. PMC: 5853376. DOI: 10.1093/infdis/jix451. View

2.
Li C, Culhane M, Schroeder D, Cheeran M, Galina Pantoja L, Jansen M . Vaccination decreases the risk of influenza A virus reassortment but not genetic variation in pigs. Elife. 2022; 11. PMC: 9439680. DOI: 10.7554/eLife.78618. View

3.
Ang B, Lim T, Wang L . Nipah Virus Infection. J Clin Microbiol. 2018; 56(6). PMC: 5971524. DOI: 10.1128/JCM.01875-17. View

4.
Al Hossain F, Lover A, Corey G, Reich N, Rahman T . FluSense: A Contactless Syndromic Surveillance Platform for Influenza-Like Illness in Hospital Waiting Areas. Proc ACM Interact Mob Wearable Ubiquitous Technol. 2022; 4(1). PMC: 9286491. DOI: 10.1145/3381014. View

5.
De Clercq E . Recent highlights in the development of new antiviral drugs. Curr Opin Microbiol. 2005; 8(5):552-60. PMC: 7108330. DOI: 10.1016/j.mib.2005.08.010. View